Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials

More than 150 million people worldwide are chronically infected with hepatitis C virus (HCV) and face higher risk of cirrhosis and hepatocellular carcinoma. Highly effective HCV treatments have recently been developed; however, they are costly and therefore poorly suited for application in resource-...

Descripción completa

Detalles Bibliográficos
Autores principales: Loftfield, Erikka, O’Brien, Thomas R., Pfeiffer, Ruth M., Howell, Charles D., Horst, Ron, Prokunina-Olsson, Ludmila, Weinstein, Stephanie J., Albanes, Demetrius, Morgan, Timothy R., Freedman, Neal D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104464/
https://www.ncbi.nlm.nih.gov/pubmed/27832143
http://dx.doi.org/10.1371/journal.pone.0166036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104464/
https://www.ncbi.nlm.nih.gov/pubmed/27832143
http://dx.doi.org/10.1371/journal.pone.0166036

Ejemplares similares